Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 9, Pages 5053
Publisher
MDPI AG
Online
2022-05-03
DOI
10.3390/ijms23095053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease
- (2022) Uri Nimrod Ramírez-Jarquín et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
- (2021) Marlene F. Schmidt et al. CELL DEATH AND DIFFERENTIATION
- Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
- (2021) Steven P. Langston et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
- (2021) Jiabin Lu et al. Frontiers in Pharmacology
- SENP Proteases as Potential Targets for Cancer Therapy
- (2021) Paulina Tokarz et al. Cancers
- A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
- (2021) Eric S. Lightcap et al. Science Translational Medicine
- Loss of UCHL1 rescues the defects related to Parkinson’s disease by suppressing glycolysis
- (2021) Su Jin Ham et al. Science Advances
- SUMOylation as a Therapeutic Target for Myocardial Infarction
- (2021) Wei Zhao et al. Frontiers in Cardiovascular Medicine
- The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications
- (2021) Congcong Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Angelman Syndrome: a journey through the brain
- (2020) Carina Maranga et al. FEBS Journal
- Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
- (2020) Eric K. Rowinsky et al. INVESTIGATIONAL NEW DRUGS
- SUMOylation in development and neurodegeneration
- (2020) Tak-Yu Yau et al. DEVELOPMENT
- Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts
- (2020) Arda B. Celen et al. FEBS Journal
- Current Status of SUMOylation Inhibitors
- (2020) Christopher M. Brackett et al. CURRENT MEDICINAL CHEMISTRY
- MDM2 inhibition: an important step forward in cancer therapy
- (2020) Marina Konopleva et al. LEUKEMIA
- Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
- (2020) Ainsley Mike Antao et al. Cancers
- Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux
- (2020) Qing Xiao et al. Frontiers in Pharmacology
- Targeting mitophagy in Parkinson's disease
- (2020) Emily H. Clark et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke
- (2019) Joshua D. Bernstock et al. EBioMedicine
- Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
- (2019) Jatin Shah et al. Clinical Lymphoma Myeloma & Leukemia
- 2-D08 as a SUMOylation inhibitor induced ROS accumulation mediates apoptosis of acute myeloid leukemia cells possibly through the deSUMOylation of NOX2
- (2019) Pan Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
- (2019) Min Yu et al. Frontiers in Oncology
- The many substrates and functions of NEDD4-1
- (2019) Xi Huang et al. Cell Death & Disease
- Small molecule SUMOylation activators are novel neuroprotective agents
- (2018) Katherine Krajnak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy
- (2018) Arthur F. Kluge et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the SUMO Pathway Primes All-transRetinoic Acid–Induced Differentiation of Nonpromyelocytic Acute Myeloid Leukemias
- (2018) Hayeon Baik et al. CANCER RESEARCH
- Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2
- (2018) Joshua D. Bernstock et al. FASEB JOURNAL
- A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
- (2018) Marc L Hyer et al. NATURE MEDICINE
- High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma
- (2018) Jian‑Dong Shen et al. Oncology Letters
- Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity
- (2018) Angela McHugh et al. Oncotarget
- Dual Function of USP14 Deubiquitinase in Cellular Proteasomal Activity and Autophagic Flux
- (2018) Eunkyoung Kim et al. Cell Reports
- Cerebral Ischemia Increases Small Ubiquitin-Like Modifier Conjugation within Human Penumbral Tissue: Radiological–Pathological Correlation
- (2018) Joshua D. Bernstock et al. Frontiers in Neurology
- USP14 inhibition corrects an in vivo model of impaired mitophagy
- (2018) Joy Chakraborty et al. EMBO Molecular Medicine
- K-Ras lysine-42 is crucial for its signaling, cell migration and invasion
- (2018) Byeong Hyeok Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies
- (2018) Xiaoguang Liu et al. HUMAN MOLECULAR GENETICS
- Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
- (2017) Brijesh Kumar Singh et al. HUMAN MOLECULAR GENETICS
- An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons
- (2017) Monica Boselli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- USP1–UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses
- (2017) Zhongxia Yu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma
- (2017) Dan T. Vogl et al. LEUKEMIA & LYMPHOMA
- Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
- (2017) Xingyue He et al. Nature Chemical Biology
- Deubiquitylating enzymes and drug discovery: emerging opportunities
- (2017) Jeanine A. Harrigan et al. NATURE REVIEWS DRUG DISCOVERY
- Proteasome inhibitors: structure and function
- (2017) Ana T. Nunes et al. SEMINARS IN ONCOLOGY
- Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation
- (2017) Xingjie Ma et al. Oncotarget
- Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca2+-ATPase 2a
- (2017) Wenjing Hu et al. Scientific Reports
- A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways
- (2017) Katherine Zlotkowski et al. SLAS Discovery
- Ubiquitin-dependent and independent roles of SUMO in proteostasis
- (2016) Frauke Liebelt et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping
- (2016) Ashutosh Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility
- (2016) Loredana Vecchione et al. CELL
- UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised HeartsNovelty and Significance
- (2016) Manish K. Gupta et al. CIRCULATION RESEARCH
- Ixazomib: First Global Approval
- (2016) Matt Shirley DRUGS
- Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia
- (2016) Hongmei Luo et al. Journal of Hematology & Oncology
- Aβ-Induced Synaptic Alterations Require the E3 Ubiquitin Ligase Nedd4-1
- (2016) Elizabeth M. Rodrigues et al. JOURNAL OF NEUROSCIENCE
- Overexpression and Biological Function of Ubiquitin-Specific Protease 42 in Gastric Cancer
- (2016) Kun Hou et al. PLoS One
- Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis
- (2016) Nina Yu et al. OncoTargets and Therapy
- Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation
- (2016) Jingjing Wu et al. Oncotarget
- Involvement of activated SUMO-2 conjugation in cardiomyopathy
- (2015) Eun Young Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer
- (2015) Xiaoke Liu et al. Journal of Hematology & Oncology
- SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy
- (2015) Eun Young Kim et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy
- (2015) Rong Cai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
- (2015) Axel Freischmidt et al. NATURE NEUROSCIENCE
- Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy
- (2015) Katharina Pukaß et al. Frontiers in Cellular Neuroscience
- Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
- (2015) Changwon Kho et al. Nature Communications
- UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression
- (2015) Sajjad Hussain et al. Oncotarget
- A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver
- (2015) Miyuki Suzawa et al. eLife
- Synthesis of 2′,3′,4′-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation
- (2014) Yeong Sang Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
- (2014) A. Hoellein et al. BLOOD
- Cellular ubiquitin pool dynamics and homeostasis
- (2014) Chul-Woo Park et al. BMB Reports
- Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities
- (2014) Ryan J. Davis et al. CANCER CELL
- SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway
- (2014) Jianmin Gu et al. CARDIOVASCULAR RESEARCH
- Sumo E2 Enzyme UBC9 Is Required for Efficient Protein Quality Control in Cardiomyocytes
- (2014) Manish K. Gupta et al. CIRCULATION RESEARCH
- Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets
- (2014) B. Stefanska et al. CLINICAL CANCER RESEARCH
- Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata
- (2014) Misao Takemoto et al. JOURNAL OF ANTIBIOTICS
- The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer
- (2014) Markus E. Diefenbacher et al. JOURNAL OF CLINICAL INVESTIGATION
- Important Role of SUMOylation of Spliceosome Factors in Prostate Cancer Cells
- (2014) Donghua Wen et al. JOURNAL OF PROTEOME RESEARCH
- The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
- (2014) Baris Bingol et al. NATURE
- Extended ubiquitin species are protein-based DUB inhibitors
- (2014) Daria Krutauz et al. Nature Chemical Biology
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
- (2014) Sian E. Davies et al. NEUROBIOLOGY OF DISEASE
- HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response
- (2014) B. Rotblat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination
- (2014) Hong-Bin Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
- (2014) Linda Lee et al. Scientific Reports
- Spectomycin B1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E2
- (2013) Mikako Hirohama et al. ACS Chemical Biology
- Elevated TRAF2/6 expression in Parkinson’s disease is caused by the loss of Parkin E3 ligase activity
- (2013) Ji-Yun Chung et al. LABORATORY INVESTIGATION
- Expression of HAUSP in gliomas correlates with disease progression and survival of patients
- (2013) CHUANDONG CHENG et al. ONCOLOGY REPORTS
- SUMO-1 Gene Transfer Improves Cardiac Function in a Large-Animal Model of Heart Failure
- (2013) L. Tilemann et al. Science Translational Medicine
- The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer Cells
- (2013) Yadi Wu et al. Cell Reports
- PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
- (2012) Julia Hoefer et al. AMERICAN JOURNAL OF PATHOLOGY
- Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors
- (2012) Masaharu Uno et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma
- (2012) Elisa Gallerani et al. EUROPEAN JOURNAL OF CANCER
- Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration
- (2012) Y.-D. Kwak et al. JOURNAL OF NEUROSCIENCE
- Next-generation proteasome inhibitor approved in multiple myeloma
- (2012) Alla Katsnelson NATURE BIOTECHNOLOGY
- Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression
- (2012) Weiwei Huang et al. PLoS One
- Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition
- (2012) T. Bawa-Khalfe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defective sumoylation pathway directs congenital heart disease
- (2011) Jun Wang et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- Development of Small Molecule Inhibitors and Probes of Human SUMO Deconjugating Proteases
- (2011) Victoria E. Albrow et al. CHEMISTRY & BIOLOGY
- Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation
- (2011) Silvia Zucchelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sumoylation inhibits α-synuclein aggregation and toxicity
- (2011) Petranka Krumova et al. JOURNAL OF CELL BIOLOGY
- Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction
- (2011) Eun Young Kim et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- SUMO1-dependent modulation of SERCA2a in heart failure
- (2011) Changwon Kho et al. NATURE
- Ubiquitin ligase Nedd4 promotes -synuclein degradation by the endosomal-lysosomal pathway
- (2011) G. K. Tofaris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
- (2011) J. D. Kessler et al. SCIENCE
- The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma
- (2010) G. W. Xu et al. BLOOD
- Loss of HRD1-Mediated Protein Degradation Causes Amyloid Precursor Protein Accumulation and Amyloid- Generation
- (2010) M. Kaneko et al. JOURNAL OF NEUROSCIENCE
- The role of parkin in familial and sporadic Parkinson's disease
- (2010) Ted M. Dawson et al. MOVEMENT DISORDERS
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14
- (2010) Byung-Hoon Lee et al. NATURE
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
- (2009) J. J. Driscoll et al. BLOOD
- Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk
- (2009) Thomas Dünnebier et al. BREAST CANCER RESEARCH AND TREATMENT
- Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
- (2009) Isao Fukuda et al. CHEMISTRY & BIOLOGY
- Kerriamycin B inhibits protein SUMOylation
- (2009) Isao Fukuda et al. JOURNAL OF ANTIBIOTICS
- SUMOylation participates in induction of ischemic tolerance
- (2009) Yang ja Lee et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of Synaptic Structure by Ubiquitin C-Terminal Hydrolase L1
- (2009) A. E. Cartier et al. JOURNAL OF NEUROSCIENCE
- Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains
- (2009) Stéphanie Baulac et al. Molecular Neurodegeneration
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
- (2009) Brenda A. Schulman et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: A genetic association study
- (2009) Kyungsook Ahn et al. NEUROSCIENCE LETTERS
- Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levels
- (2008) Yu-Qian Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients
- (2008) Salla Ruosaari et al. BMC Medical Genomics
- Cerebral ischemiastroke and small ubiquitin-like modifier (SUMO) conjugation a new target for therapeutic intervention?
- (2008) Wei Yang et al. JOURNAL OF NEUROCHEMISTRY
- A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation
- (2008) Qing Liu et al. Molecular Neurodegeneration
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now